Early Detection &
Interception of Cancer
Current Practice Recommendations &
Novel Emerging Approaches
A focused one-day educational program exploring cancer screening,
high-risk populations, hereditary predisposition, precursor conditions
and emerging technologies designed to detect cancer earlier.
SEPTEMBER 14, 2026
ONE DAY
VIDEO COURSE
Videos Only
This product contains the 2026 course video recordings only.
Slides, PDFs and downloadable lecture handouts are not included.
How Can We Detect Cancer
Before It Becomes Advanced Disease?
Cancer screening and early detection are rapidly evolving. Established
screening programs remain central to preventive care, while genetics,
risk stratification, biomarkers, advanced imaging and multi-cancer
detection technologies are creating new possibilities.
The Harvard Early Detection and Interception
of Cancer 2026 program reviews both sides of this changing landscape:
what clinicians should be doing today and
which emerging approaches may influence future practice.
The program also examines patients who may require more than routine
population-based screening, including individuals with inherited cancer
predisposition, precursor lesions, clonal hematologic conditions and other
high-risk features.
Screen → Identify Risk → Detect → Intercept
Apply Current Screening Recommendations
Review evidence-based screening approaches across multiple common malignancies.
Recognize High-Risk Individuals
Use family history, genetics, precursor conditions and clinical risk factors
to identify patients requiring additional evaluation.
Find Disease Earlier
Understand specialty-specific approaches to identifying early malignancy
and premalignant disease.
Manage Precursor Conditions
Explore management and referral strategies for conditions associated
with increased future cancer risk.
Evaluate Emerging Detection Technologies
Examine MCED testing, whole-body imaging and other evolving approaches,
including both their potential and limitations.
Program Details
September 14, 2026
One Day
Videos Only
Oncology • Hematology • Internal Medicine • Cancer Prevention • Genetics
2026
What You’ll Learn
Identify and implement current approaches to cancer screening in clinical practice.
Improve early detection strategies for patients with increased cancer risk.
Understand the role of genetic testing and hereditary risk assessment.
Recognize conditions requiring surveillance, management or specialist referral.
Evaluate new approaches to cancer detection and their potential clinical role.
Consider how novel detection strategies could potentially fit into future clinical practice.
Monday, September 14, 2026
A one-day journey from established screening practice to the future of early cancer detection.
Starting With the Front Line of Cancer Detection
Welcome and Kick Off
Sapna Syngal • Betsy O’Donnell
Advancing Early Detection and Interception from the Perspective of the Primary Care Physician
Elizabeth Housman
Find Risk Before Disease
Genetics 101: Genetic Testing for Inherited Cancer Predisposition in Your Practice
Karina Franca
Management of Hereditary Cancer Predisposition in Your Practice
Huma Rana
The PREMM plus Model / An Easy Way to Identify At Risk Individuals in Your Practice
Sapna Syngal
Detecting & Managing Precursor Disease
Management of DCIS and Other Breast Cancer Precursors
Emily Gatof
Screening and Early Detection of Gynecologic Malignancies
Colleen Feltmate
Early Signals Beyond Traditional Solid-Tumor Screening
Screening and Early Detection of Dermatologic Malignancies
Vinod Nambudiri
Unexplained Cytopenia – When to Consider Clonal Hematopoiesis and MDS
Lachelle Weeks
Intercepting MGUS and Smoldering Myeloma
Irene Ghobrial
Screening Across Major Cancer Types
Michael Serzan
Nicolette J Rodriguez
Anuradha Ramaswamy
Bicky Thapa
Cancer Types & Precursor Conditions
The curriculum extends across both solid tumors and hematologic precursor conditions.
Beyond Traditional Screening
The program does not focus only on established guidelines. It also examines
technologies that may influence the future of cancer detection.
MULTI-CANCER EARLY DETECTION
Examine the evolving role of MCED testing and questions surrounding readiness
for broader clinical use.
WHOLE-BODY IMAGING
Review both the promises and potential pitfalls of whole-body imaging
for screening and early cancer detection.
GENETIC RISK ASSESSMENT
Explore inherited cancer predisposition and practical approaches
to identifying patients who may benefit from genetic evaluation.
A Broad Early-Detection Curriculum
Cancer Screening
Early Detection
Cancer Prevention
High-Risk Populations
Hereditary Cancer
Genetic Testing
PREMM Plus
DCIS
Clonal Hematopoiesis
MDS
MGUS
Smoldering Myeloma
MCED
Whole-Body Imaging
For Clinicians Focused on Finding Cancer Earlier
Particularly relevant for healthcare professionals involved in screening,
risk assessment, cancer prevention and early diagnosis.
2026 Video Course
Earlier Recognition Can Change
the Clinical Pathway
Cancer prevention and screening are no longer limited to a single test
performed at a certain age. Modern risk assessment increasingly requires
clinicians to consider family history, inherited predisposition,
premalignant disease and specialty-specific risk.
At the same time, emerging technologies such as MCED testing and
whole-body imaging raise important questions about evidence,
implementation, limitations and appropriate use.
This program brings these areas together so clinicians can review
current practice recommendations
while also understanding the
new approaches shaping the future of early detection.
Identify Risk.
Detect Earlier.
Understand What Comes Next.
A focused educational program connecting current cancer screening practice
with hereditary risk assessment, precursor conditions and emerging
approaches to earlier cancer detection.
Reviews
There are no reviews yet.